Page 103 - JCTR-11-2

Journal of Clinical and
Translational Research Review of research landscapes and quality

Figure 1. Outline of the flow of information through the two phases of the systematic review. Adapted from Haddaway et al., (2022). 30
(i) Institution and qualification of the corresponding (xi) Drugs, devices/tools, surgical, psychological, or health
author/s; services. (Table A5)
(ii) Number of authors, institutions, and expertise; 2.4. Research quality
(iii) Numbers of international collaborating authors and
institutions; In Phase 2, the research quality will be assessed based
(iv) Numbers of study sites; on various criteria across three domains: relevance,
(v) Journal type: Local, regional, or international; open credibility, and usefulness (Table 1). All reviewers will
access or traditional subscription-based; general or learn the principles of clinical epidemiology through a
discipline-specific; workshop and reach a consensual understanding of the
(vi) Setting: Healthcare facility (hospital, clinic, etc.) or terms used to represent research quality in this project.
community; During the workshop, we will implement a training
(vii) Type of study: Audit versus research; secondary session for all reviewers, in which all reviewers will read
(reviews) or primary (diagnostic, prognostic, etiologic, and score the same articles. Each item will be scored
or interventional); clinical or non-clinical (laboratory, 1 if present, and 0 when absent. This will be followed
public health, health service, etc.); by a discussion on any similarities or differences in the
(viii) Data-collection design; quality assessment and scores to ensure uniformity in the
(ix) Date of study conducted, completed, and published; understanding of the quality domains when applied to
(x) Health conditions studied, and/or organ systems involved; the actual screening process. We will also determine the

Volume 11 Issue 2 (2025) 97 doi: 10.36922/jctr.24.00071